Examples of 'l-asparaginase' in a sentence
Meaning of "l-asparaginase"
L-asparaginase is a noun referring to an enzyme that is used as a medication and in food manufacturing
How to use "l-asparaginase" in a sentence
Basic
Advanced
l-asparaginase
L-asparaginase activity is checked in the supernatant.
One of the drugs used in the treatment of all is l-asparaginase enzyme.
Activity of L-Asparaginase was determined in total blood.
History of serious thrombosis with prior L-asparaginase therapy.
L-asparaginase as part of combination therapy.
In this study, the production of l-asparaginase by eight strains of aspergillus fungi was assessed.
L-asparaginase acts by inhibiting the production of the amino acid asparagine in the body.
A fixed quantity of anti-asparaginase IgG inhibits a fixed quantity of L-asparaginase.
Methods for screening l-asparaginase producing organisms in solid and liquid medium were tested, e.
One case of pancreatitis with simultaneous acute parotitis has been described with L-asparaginase treatment.
The l-asparaginase is an enzyme used as a chemotherapeutic agent for the treatment of human cancer.
Because of this there is a possibility that L-asparaginase may increase the toxicity of other medications.
L-asparaginase is a protein used for the treatment of acute lymphoblastic leukemia and other lymphoid malignancies.
The completed analyses demonstrated an apparent sequence identity between the two commercial L-asparaginase II enzymes.
It is a form of L-asparaginase which has undergone PEGylation.
See also
Preferably the compositions of the present invention also containing native L-asparaginase in the aqueous phase.
Residual L-asparaginase activity was measured in the supernatant.
Expression, purification and evaluation of recombinant L-asparaginase in mehthylotrophic yeast Pichia pastoris.
Residual L-asparaginase activity is measured in the supernatant.
These findings were similar to those observed in the native E. coli L-asparaginase treatment arm.
The L-asparaginase activity is then assayed in the plasma and in the RBCs.
Streptomyces enissocaesilis produces L-asparaginase.
Administration of L-asparaginase after rather than before corticosteroids reportedly has produced fewer hypersensitivity reactions.
In this way, the search for new sources of l-asparaginase becomes indispensable.
L-asparaginase II was sequenced as follows.
We took as example the L-asparaginase protein of Erwinia chyrsanthemi.
L-asparaginase II is located in the periplasm and has a high affinity for L-asparagine.
An exemplary enzyme effective as anti-neoplastic agents include L-asparaginase.
L-asparaginase I is located in the cytosol and has a low affinity for asparagine.
Cells are refractory to methotrexate for up to 10 days following a single dose of L-asparaginase.
Oncological protocols that employ L-asparaginase associated with doses of glucocorticoids can provoke transitory DM.
The invention applies to all forms of asparaginase, for example L-asparaginase.
Production of l-asparaginase ( asp3 ) from saccharomyces cerevisiae expressed in pichia pastoris.
One case of toxic epidermal necrolysis ( Lyell ‘ s syndrome ) has been described in association with L-asparaginase.
The improved liposomal formulations of L-asparaginase activity makes use of extruded vesicles ( VET ).
L-Asparaginase Acute lymphocytic leukemia, mast cell tumors.
Effect of pH on L-asparaginase stability.
L-Asparaginase Acute lymphocytic leukemia, mast.
The red corpuscles encapsulating the L-asparaginase are called L-Aspa RBC.
The L-asparaginase most frequently used is isolated from E. coli.
In the United States, pegaspartase is used in place of L-asparaginase.
Anti-leukaemic effect of L-asparaginase is related to a sustained L-asparagine depletion.
The obtained sequences were also compared to the subunit structure of the K12 L-asparaginase II enzyme.
ONCASPAR ®, a pegylated L-asparaginase has been approved for treating hypersensitive ALL patients.
Sonic treatment permitted recovery of 95 % of L-asparaginase from cells.
Further studies suggested that l-asparaginase (ASRLG1) could serve as a novel prognostic biomarker in EEC.
A method according to any of Claims 1 to 5, wherein said molecule is L-asparaginase.
Below 5 µg / mL anti-asparaginase IgG, L-asparaginase activity is not inhibited.
L-asparaginase ( L-ASP ) is a universal component of therapy for acute lymphoblastic leukemia ( ALL ).
History of serious hemorrhagic events with prior L-asparaginase therapy see section 4.4.
